Equitec Proprietary Markets, LLC Bristol Myers Squibb CO Call Options Transaction History

Equitec Proprietary Markets, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Jul 20, 2021	SELL	$61.91 - $67.42 $755,302 - $822,524	-12,200 Closed	0 $0
Q4 2020 Jan 26, 2021	BUY	$57.74 - $65.43 $127,028 - $143,946	2,200 Added 22.0%	12,200 $757,000
Q3 2020 Oct 13, 2020	BUY	$57.43 - $63.64 $574,300 - $636,400	10,000 New	10,000 $603,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Equitec Proprietary Markets, LLC, based on Form 13F filings with the SEC.

Stay updated on Equitec Proprietary Markets, LLC with notifications on news.